Efficacy of induction chemotherapy in lymph node-positive stage III nasopharyngeal carcinoma and identification of beneficiaries based on clinical features: A propensity score matching analysis

鼻咽癌 倾向得分匹配 肿瘤科 医学 阶段(地层学) 诱导化疗 内科学 化疗 放化疗 生存分析 胃肠病学 生物 放射治疗 古生物学
作者
Yao-Can Xu,Kai-Hua Chen,Yong Liang,Kequan Chen,Zhongguo Liang,Fanyan Zeng,Ling Li,Song Qu,Xiaodong Zhu
出处
期刊:Oral Oncology [Elsevier BV]
卷期号:146: 106554-106554 被引量:3
标识
DOI:10.1016/j.oraloncology.2023.106554
摘要

To investigate the role of induction chemotherapy (IC) in lymph node-positive (LN-positive) stage III nasopharyngeal carcinoma (NPC) receiving concurrent chemoradiotherapy (CCRT).In total, 627 patients with newly diagnosed LN-positive stage III NPC receiving CCRT or IC plus CCRT were included. The primary endpoint was progression-free survival (PFS). Propensity-score matching (PSM) was conducted to balance the intergroup covariates. Kaplan-Meier method with log-rank test was employed to compare survival curves. Subgroup analyses were conducted based on baseline characteristics.After 1:1 PSM, 414 patients were identified (207 patients per group). Compared with CCRT, IC plus CCRT provided better survival (5-year PFS 88.4% vs. 78.6%, P = 0.01; overall survival [OS] 94.8% vs. 85.3%, P = 0.003; and distant metastasis-free survival [DMFS] 93.1% vs. 85.6%, P = 0.03). The IC beneficial effects on PFS were mainly present in patients with grade 2-3 ENE, elevated serum lactate dehydrogenase (LDH > 170U/L), and N2 disease. Patients with grade 2 CNN had comparable PFS benefits to those with grade 0-1 CNN. For patients with grade 0-1 ENE combined with LDH ≤ 170U/L, survival between the two groups was similar with 5-year PFS 93.6% vs. 90.4% (P = 0.50), OS 94.2% vs. 93.0% (P = 0.72), and DMFS 98.6% vs. 97.7% (P = 0.98).Adding IC before CCRT improved survival in LN-positive stage III NPC patients. Additional IC did not provide better survival for patients with grade 0-1 ENE combined with LDH ≤ 170U/L and could be avoided in this population. CNN may not be a good risk factor for tailoring a personalized treatment plan.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
爆米花的应助被ZRH采纳,获得10
刚刚
夜子发布了新的文献求助10
1秒前
马静雨发布了新的文献求助10
2秒前
打打的应助被ww采纳,获得10
3秒前
123完成签到,获得积分20
4秒前
土豪的德天完成签到,获得积分10
4秒前
崔世强发布了新的文献求助10
4秒前
5秒前
橘生淮南完成签到,获得积分10
5秒前
yan发布了新的文献求助10
6秒前
Ami轩完成签到 ,获得积分10
7秒前
老妖怪完成签到,获得积分10
8秒前
8秒前
Ava的应助被hhh采纳,获得10
8秒前
oylf完成签到,获得积分10
9秒前
万能图书馆的应助被洁净宝莹采纳,获得10
10秒前
Hysen_L完成签到,获得积分10
10秒前
ding的应助被wg采纳,获得10
11秒前
11秒前
cen发布了新的文献求助10
11秒前
11秒前
11秒前
JamesPei的应助被qi采纳,获得10
11秒前
12秒前
薛洋完成签到,获得积分10
12秒前
12秒前
13秒前
ghroth完成签到,获得积分10
14秒前
ww完成签到,获得积分10
15秒前
奀甭的夯兲完成签到,获得积分10
15秒前
15秒前
xxxx发布了新的文献求助10
15秒前
15秒前
15秒前
石石石开发布了新的文献求助10
15秒前
隐形曼青的应助被酷酷的仇天采纳,获得10
15秒前
庞伟泽发布了新的文献求助10
16秒前
Nole的应助被糊涂的缘分采纳,获得30
16秒前
哎呦喂完成签到,获得积分10
16秒前
16秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8188885
求助须知:如何正确求助?哪些是违规求助? 9576493
关于积分的说明 21847858
捐赠科研通 7786920
什么是DOI,文献DOI怎么找? 3435460
关于科研通互助平台的介绍 2559669
邀请新用户注册赠送积分活动 2482383